课题基金 / 基金详情

Regulation of Mast Cell Homeostasis by Interleukin-10

Regulation of Mast Cell Homeostasis by Interleukin-10
Interleukin-10 对肥大细胞稳态的调节
批准号:
7071472
负责人:
John J Ryan
金额:
$33.21万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2007-01-31

项目摘要

项目成果

John J Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
肥大细胞是过敏反应中最具特征的效应器之一。肥大细胞效应功能现在不仅与过敏性疾病有关,如
英文摘要
Mast cells are one of the best-characterized effectors in the allergic response. Mast cell effector functions are now being tied not only to allergic diseases such as asthma, but also to arthritis, multiple sclerosis, and coronary artery disease. Thus, understanding mast call development, function, and survival is clinically significant. Our laboratory has been investigating cytokine-mediated regulation of mast cell biology as a model of immune homeostasis. In this regard, we have found IL-10 to be a multi-functional regulator of mast cell homeostasis. Intedeukin (IL)-10 is a potent regulatory cytokine involved in the Th1 and Th2 immune responses, with close ties to inflammatory diseases such as multiple sclerosis, systemic lupus erythematosus and Crohn's disease. Using IL-10 signaling as a model system, this application will assess the homeostatic effects of Th2 cytokines on mast cell development, function, and survival. Our Specific Aims are: I. To determine the mechanism by which IL-10 induces apoptosis of developing mast cell progenitors II. To determine the mechanism by which IL-10 alters mast cell function II1. III.To determine the mechanism by which co-stimulation with IL-10+IL-4 induces cell cycle arrest and apoptosis of cultured mast cells These aims focus on the role of the transcription factor Stat3 in IL-10 signaling, and will employ primary bone marow-derived mast call populations as an assay system. The goals of this proposal will be accomplished by standard tissue culture and molecular biology approaches, augmented by oligonucleotide microarray analyses of the IL-10-regulated mast call transcriptome and the role of Stat3 in this gene regulation. When completed, these studies will offer a more complete understanding of immune homeostasis and the role Th2 cytokines have in this process. Though most directly related to allergic disease, these studies will impact our understanding of inflammatory diseases such as multiple sclerosis, arthritis, and cardiovascular disease.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses.
最前沿:遗传变异影响 Fc epsilonRI 诱导的肥大细胞激活和过敏反应。
DOI: 10.4049/jimmunol.179.2.740
发表时间: 2007
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Yamashita,Yumi, Charles,Nicolas, Furumoto,Yasuko, Odom,Sandra, Yamashita,Toshiyuki, Gilfillan,AlasdairM, Constant,Stephanie, Bower,MollyA, Ryan,JohnJ, Rivera,Juan]
通讯作者: Rivera,Juan
Galectin-1 promotes an M2 macrophage response to polydioxanone scaffolds.
Galectin-1 促进 M2 巨噬细胞对聚二氧环己酮支架的反应。
DOI: 10.1002/jbm.a.36113
发表时间: 2017-09
期刊: Journal of biomedical materials research. Part A
影响因子: --
作者: [Abebayehu D, Spence A, Boyan BD, Schwartz Z, Ryan JJ, McClure MJ]
通讯作者: McClure MJ
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
P2X3 is a Female-Dominant Amplifier of Mast Cell Function
GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33
  • 批准号:
    10459343
  • 项目类别:
  • 资助金额:
    $37.19万
  • 财政年份:
    2018
  • 负责人:
    John J Ryan
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: